1. Home
  2. LSBK vs ARMP Comparison

LSBK vs ARMP Comparison

Compare LSBK & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSBK
  • ARMP
  • Stock Information
  • Founded
  • LSBK 1891
  • ARMP N/A
  • Country
  • LSBK United States
  • ARMP United States
  • Employees
  • LSBK N/A
  • ARMP N/A
  • Industry
  • LSBK Savings Institutions
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LSBK Finance
  • ARMP Health Care
  • Exchange
  • LSBK Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • LSBK 91.1M
  • ARMP 80.0M
  • IPO Year
  • LSBK 2006
  • ARMP N/A
  • Fundamental
  • Price
  • LSBK $15.80
  • ARMP $1.95
  • Analyst Decision
  • LSBK
  • ARMP Strong Buy
  • Analyst Count
  • LSBK 0
  • ARMP 1
  • Target Price
  • LSBK N/A
  • ARMP $7.00
  • AVG Volume (30 Days)
  • LSBK 4.1K
  • ARMP 8.0K
  • Earning Date
  • LSBK 01-24-2025
  • ARMP 03-20-2025
  • Dividend Yield
  • LSBK 4.56%
  • ARMP N/A
  • EPS Growth
  • LSBK 7.32
  • ARMP N/A
  • EPS
  • LSBK 0.88
  • ARMP N/A
  • Revenue
  • LSBK $25,846,000.00
  • ARMP $5,467,000.00
  • Revenue This Year
  • LSBK N/A
  • ARMP $23.87
  • Revenue Next Year
  • LSBK N/A
  • ARMP N/A
  • P/E Ratio
  • LSBK $17.95
  • ARMP N/A
  • Revenue Growth
  • LSBK N/A
  • ARMP 34.92
  • 52 Week Low
  • LSBK $10.30
  • ARMP $1.80
  • 52 Week High
  • LSBK $16.56
  • ARMP $4.48
  • Technical
  • Relative Strength Index (RSI)
  • LSBK 64.39
  • ARMP 42.06
  • Support Level
  • LSBK $15.51
  • ARMP $1.89
  • Resistance Level
  • LSBK $16.56
  • ARMP $2.08
  • Average True Range (ATR)
  • LSBK 0.42
  • ARMP 0.10
  • MACD
  • LSBK 0.08
  • ARMP -0.01
  • Stochastic Oscillator
  • LSBK 75.95
  • ARMP 18.18

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: